Kalos Management’s Gyre Therapeutics GYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
2021
Q3
$58K Sell
2021
Q2
$74K Sell
2021
Q1
$83K Hold
2020
Q4
$112K Hold
2020
Q3
$79K Sell
2020
Q2
$107K Sell
2020
Q1
$86K Buy
2019
Q4
$121K Hold
2019
Q3
$90K Buy
2019
Q2
$127K Buy
2019
Q1
$130K Sell
2018
Q4
$147K Buy
2018
Q3
$180K Buy
2018
Q2
$244K Buy
2018
Q1
Sell
2017
Q4
$222K Buy